What Has Been The Evolution of the Jynneos Market in Recent Years?
The jynneos market has seen considerable growth due to a variety of factors.
• In recent times, the jynneos market has seen a remarkable size increase of XX (HCAGR). Expectations are for the market to expand from a value of $XX million in 2024 to $XX million in 2025, showcasing a compound annual growth rate (CAGR) of XX%.
Factors that contribute to this growth during the historical period include the rising menace of newly emerging infectious diseases, heightened government vaccination funding, an upswing in global travel, increased public health drives, and enhancements in the vaccine supply chain.
What Is the Forecasted Market Size and Growth Rate for The Jynneos Market Size In The Coming Years?
The jynneos market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the jynneos market size is forecasted to see a XX (FCAGR) increase. By 2029, it is projected to reach a valuation of $XX million, growing at a compound annual growth rate (CAGR) of XX%.
The predicted growth during the forecast period is likely due to the increasing trend towards infection prevention, personalized medicines, a heightened focus on preparedness for infectious diseases within the health system, investment in vaccine production infrastructure, and a rise in immunocompromised individuals. The forecast period will be marked by trends such as treatment advancements, mRNA vaccine technology, the use of AI in vaccine development, the introduction of advanced adjuvant systems, and innovative formulations.
What Factors Are Driving Growth In The Jynneos Market?
The growth of the Jynneos market is anticipated to be propelled by the increasing monkeypox incidences. Monkeypox, a viral infection caused by the Monkeypox virus from the orthopoxvirus family, is becoming more common due to the rise in global travel and enhanced interaction between wildlife and humans, enabling infectious agents to spread quickly, leading to isolated epidemics. Jynneos serves as an effective deterrent against the disease in at-risk individuals and is safer for immunocompromised individuals compared to conventional smallpox vaccines. For instance, the European Centre for Disease Prevention and Control disclosed in September 2024 that over 100,000 verified monkeypox (MPXV clade I and II) infections, including over 200 fatalities, were reported by 120+ countries worldwide from January 2022 to July 2024. In May 2022, the Sweden-based European Centre for Disease Prevention and Control (ECDC) reported 1,152 suspected monkeypox cases from January to April 2022, resulting in 55 deaths and a case-fatality rate of 4.8%, affecting 54 health zones in 14 provinces. Thus, the escalating number of monkeypox cases is fueling the expansion of the Jynneos market.
What Are The Main Segments Of The Global Jynneos Market?
The jynneos market covered in this report is segmented –
1) By Indication: Prevention of Monkeypox, Prevention of Smallpox
2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution
3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations
4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers
Pre-Book The Jynneos Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Jynneos Market?
Major companies operating in the jynneos market include:
• Bavarian Nordic A/S
What Is The Most Dominant Region In The Jynneos Market?
North America was the largest region in the jynneos market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
